Tirzepatide for cannabis use disorder
Treatments studied
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study tests whether a medication called tirzepatide (originally developed for diabetes) can help people reduce or stop cannabis use. It is for adults who use cannabis frequently and are motivated to seek treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with moderate to severe cannabis use disorder (at least 4 out of 11 symptoms)
- You use cannabis 4 or more days a week
- You are actively looking for treatment for your cannabis use
- Your body mass index (BMI) is 22 or higher (ask your doctor if you're unsure)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a treatment called repetitive transcranial magnetic stimulation (a non-surgical magnetic stimulation to the brain) can help people reduce or stop cannabis use. You may be eligible if you have cannabis use disorder and meet specific safety and symptom criteria.
This trial tests if tirzepatide, a hormone-like medicine, can help people with severe cannabis use disorder reduce their cannabis use. It may work by changing how your body responds to certain signals.
This trial tests whether tirzepatide (a medication that affects appetite and metabolism) can help people reduce or stop cannabis use. It is for adults who want treatment for cannabis use disorder.
This study tests whether a medication called tirzepatide (a once-weekly injection) can help people reduce their alcohol consumption. It is for people who drink heavily, have a high BMI, and are actively seeking help to drink less.
This study tests whether a weekly injection of tirzepatide (a medicine for weight and blood sugar) combined with cognitive-behavioral therapy (counseling) can help people with alcohol use disorder who are also overweight or obese. By reducing alcohol cravings and supporting weight loss, the treatment aims to improve both drinking and health outcomes.
This trial tests if tirzepatide, a medication that helps with appetite and blood sugar, can help people with alcohol use disorder drink less or stop drinking. You would visit the clinic regularly and receive the drug or a placebo.
Hear when a new Cannabis Use Disorder, Moderate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.